The global diabetes market has witnessed significant growth, driven by the rising prevalence of diabetes and the increasing demand for advanced treatment options. As of 2023, approximately 537 million adults are living with diabetes, and this number is expected to rise to 783 million by 2045. Innovative technologies, such as continuous glucose monitoring systems and insulin delivery devices, are transforming diabetes management, enhancing patient outcomes and quality of life.
Moreover, the market is characterized by a shift towards personalized medicine, with a growing emphasis on tailored therapies based on individual patient profiles. Increasing health awareness and government initiatives promoting diabetes prevention and management are also contributing to market expansion. Additionally, the integration of digital health solutions, including telemedicine and mobile health applications, is reshaping diabetes care delivery, making it more accessible and efficient. The combination of these factors positions the diabetes market for sustained growth in the coming years.










Title : Changes in the global incidence of diabetes over a quarter century
F Buck Willis, Christian College of Medicine
Title : Vascular health with glucagon-like peptide-1 receptor agonists
Mahir Khalil Ibrahim Jallo, Thumbay University Hospital
Title : The prowess of Overripe Banana Sweetener (OBS) in enhancing nutritive values in food and ameliorating glycaemic responses in type 2 diabetes mellitus
Wan Rosli Wan Ishak, Universiti Sains Malaysia
Title : Wound care 2.0 creating a wound care culture TM
David Navazio, Gentell
Title : Association between diabetes technology use and prevalent macrovascular disease in adults with type 1 diabetes: A cross-sectional analysis
Divanshi Trivedi, London Northwest Hospital NHS Foundation Trust
Title : Beyond the prescription: Using GLP 1 science and lifestyle coaching to prevent prediabetes and support long term blood sugar control
Keith Hersey, Founder/CEO Destroying Diabetes
Title : Intensive versus standard blood pressure control in type 2 diabetes: Cardiovascular and microvascular outcomes
Muhammad Basil Raza, East Lancashire Hospitals NHS Trust
Title : Fetomaternal outcomes in gestational diabetes mellitus with and without polycystic ovary syndrome
Vinita Singh, AIIMS
Title : Effects of a structured education program on glycemic control in type 1 diabetes
Ana Paula Franco Pacheco, Estacio University of Brasília
Title : Cardiorespiratory fitness inflammatory and neurotrophic biomarkers and cognitive function in early versus longer duration type 2 diabetes mellitus
Arbind Kumar Choudhary, All India Institute of Medical Sciences